1.5 Million U.S. Adults Have Vision-Affecting Glaucoma
By Lori Solomon HealthDay Reporter
FRIDAY, Oct. 18, 2024 -- An estimated 2.56 percent of U.S. adults ages 40 years and older have glaucoma, according to a study published online Oct. 17 in JAMA Ophthalmology.
Joshua R. Ehrlich, M.D., from University of Michigan, Ann Arbor, and colleagues used the Centers for Disease Control and Prevention Vision and Eye Health Surveillance System to estimate glaucoma prevalence among U.S. states and counties in 2022.
The researchers found that an estimated 4.22 million people were living with glaucoma in the United States in 2022. The prevalence was 1.62 percent for adults overall and 2.56 percent for those ages 40 years and older. Vision-affecting glaucoma impacted an estimated 1.49 million people (0.57 percent of adults overall and 0.91 percent among people ages 40 years and older). Geographic prevalence varied from 1.11 percent of adults in Utah to 1.95 percent in Mississippi. Prevalence was higher among Black adults versus White (3.15 and 1.42 percent, respectively). For Hispanic adults, the prevalence was 1.56 percent.
“These estimates may help provide information for the development and prioritization of public health strategies and interventions, the monitoring of epidemiologic trends, and evaluation of programs tailored for communities and populations at highest risk of glaucoma,” the authors write.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Indicators of Neuropathic Ocular Pain Identified After LASIK
TUESDAY, July 22, 2025 -- In a study published in the August issue of the American Journal of Ophthalmology, diagnostic indicators are identified for confirming chronic...
NRTI Use Linked to Risk for Primary Open-Angle Glaucoma
TUESDAY, July 8, 2025 -- Use of nucleoside and nucleotide reverse transcriptase inhibitors (NRTIs) is associated with an increased risk for primary open-angle glaucoma (POAG)...
Relative Peripheral Refraction Predicts Myopia Progression in Children
TUESDAY, June 24, 2025 -- Vertical and horizontal relative peripheral refraction (RPR) are associated with faster axial length progression and higher risk of incident myopia...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.